Stock listing

NASDAQ:ENSC Ensysce Biosciences, Inc. Stock

Home listing (NASDAQ) of Ensysce Biosciences, Inc.

Follow Ensysce Biosciences, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ENSC

$0.382 USD -0.039 (-9.2%)

Close on Nov 2, 2026

Past year -82.2% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.380 – $0.450 USDNov 2, 2026
Volume
545,371 sharesNov 2, 2026
Market cap
$7.43M USDAt the close on Nov 2, 2026 · price × 19.46M shares outstanding
52-week range
$0.230 – $2.230 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$6.24M USDMedian day 537,700 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Ensysce Biosciences, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ENSC · Home$0.382 USD-0.039 (-9.2%)545,371$0.420$0.450$0.380$0.421Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ENSC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.382-0.039-9.2%$0.420$0.450$0.380545,371
$0.421-0.017-3.9%$0.427$0.440$0.420105,957
$0.438-0.014-3.2%$0.447$0.472$0.431176,315
$0.452+0.002+0.5%$0.457$0.470$0.44059,446
$0.4500.0000.0%$0.454$0.473$0.420399,813
$0.450-0.020-4.4%$0.456$0.489$0.430293,048
$0.471-0.041-7.9%$0.518$0.523$0.470237,132
$0.511-0.009-1.7%$0.520$0.550$0.510353,400
$0.520+0.021+4.2%$0.493$0.528$0.493290,100
$0.499-0.004-0.8%$0.547$0.547$0.499302,500
$0.503-0.015-2.9%$0.520$0.525$0.500234,600
$0.518-0.080-13.4%$0.587$0.587$0.503490,700
$0.598+0.037+6.6%$0.560$0.599$0.550323,200
$0.561-0.012-2.1%$0.561$0.574$0.527415,000
$0.573+0.017+3.1%$0.536$0.620$0.5321,218,500
$0.556+0.029+5.5%$0.510$0.565$0.4851,316,200
$0.527+0.069+15.1%$0.480$0.548$0.4802,677,400
$0.458+0.029+6.8%$0.439$0.474$0.4011,256,000
$0.429-0.001-0.2%$0.436$0.439$0.417195,100
$0.430+0.011+2.6%$0.417$0.440$0.412540,300
$0.419+0.024+6.1%$0.390$0.440$0.390601,300
$0.395-0.005-1.3%$0.410$0.427$0.393173,200
$0.400-0.016-3.8%$0.420$0.420$0.395198,900
$0.416-0.001-0.2%$0.411$0.426$0.410349,200
$0.417+0.016+4.0%$0.404$0.429$0.404167,700
$0.401-0.011-2.7%$0.411$0.423$0.399210,300
$0.412+0.012+3.0%$0.405$0.419$0.401141,800
$0.400-0.015-3.6%$0.426$0.426$0.397319,600
$0.415-0.014-3.3%$0.430$0.441$0.407363,000
$0.429+0.008+1.9%$0.425$0.443$0.418200,900
$0.421-0.037-8.1%$0.450$0.458$0.419537,700
$0.458+0.005+1.1%$0.452$0.464$0.444494,700
$0.453+0.005+1.1%$0.450$0.465$0.440391,100
$0.448-0.004-0.9%$0.455$0.457$0.435382,000
$0.452-0.029-6.0%$0.476$0.476$0.440315,900
$0.481-0.006-1.2%$0.490$0.505$0.473418,900
$0.487-0.029-5.6%$0.520$0.523$0.477561,000
$0.516+0.042+8.9%$0.477$0.526$0.440940,400
$0.474+0.001+0.2%$0.480$0.498$0.461673,100
$0.473+0.017+3.7%$0.470$0.499$0.4011,448,700
$0.456+0.016+3.6%$0.440$0.459$0.412550,400
$0.440-0.003-0.7%$0.436$0.452$0.428436,700
$0.443+0.055+14.2%$0.400$0.448$0.3771,392,000
$0.388-0.005-1.3%$0.385$0.395$0.377207,700
$0.393-0.007-1.8%$0.390$0.410$0.385528,500
$0.400+0.001+0.3%$0.405$0.412$0.385486,600
$0.399-0.013-3.2%$0.400$0.410$0.390567,600
$0.412+0.009+2.2%$0.410$0.417$0.391747,400
$0.403+0.042+11.6%$0.361$0.416$0.3551,698,300
$0.361-0.012-3.2%$0.373$0.373$0.354966,700
$0.373-0.005-1.3%$0.371$0.375$0.362778,200
$0.378-0.010-2.6%$0.380$0.387$0.360911,100
$0.388+0.003+0.8%$0.369$0.390$0.3681,555,600
$0.385+0.008+2.1%$0.396$0.406$0.3622,924,400
$0.377-0.023-5.8%$0.376$0.420$0.3602,601,100
$0.400+0.051+14.6%$0.339$0.475$0.33118,710,000
$0.349-0.050-12.5%$0.380$0.382$0.3312,742,500
$0.399-0.022-5.2%$0.430$0.430$0.3701,824,400
$0.421-0.010-2.3%$0.427$0.505$0.4203,711,000
$0.431-0.089-17.1%$0.459$0.471$0.3785,198,000
$0.520-0.004-0.8%$0.484$0.550$0.47315,653,900
$0.524+0.162+44.8%$0.631$0.979$0.460498,051,900
$0.362-0.022-5.7%$0.335$0.400$0.3127,793,700
$0.384+0.104+37.1%$0.434$0.483$0.357182,036,200
$0.280+0.027+10.7%$0.247$0.294$0.247122,336,400
Ticker
NASDAQ:ENSC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Ensysce Biosciences (NASDAQ:ENSC) Q2 2026 Earnings Call

    Tue, Aug 18, 2026 · 11:00 AM ET

    Watch Transcript

  • Ensysce Biosciences (NASDAQ:ENSC) Q4 2023 Earnings Call

    Thu, Mar 21, 2024 · 11:00 AM ET

    Watch Transcript

  • Ensysce Biosciences (NASDAQ:ENSC) Q4 2022 Earnings Call

    Tue, Apr 11, 2023 · 11:00 AM ET

    Watch Transcript

Latest news

Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai

Oct 21, 2026

Closed $0.52 (+4.2%) on Oct 21, 2026

Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation

Sep 15, 2026

Closed $0.452 (-6.0%) on Sep 15, 2026

Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

Sep 14, 2026

Closed $0.481 (-1.2%) on Sep 14, 2026

Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation

Sep 2, 2026

Closed $0.443 (+14.2%) on Sep 2, 2026

Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study

Aug 31, 2026

Closed $0.393 (-1.8%) on Aug 31, 2026

Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Aug 13, 2026

Closed $0.40 (+14.6%) on Aug 14, 2026

Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing

Aug 6, 2026

Closed $0.524 (+44.8%) on Aug 6, 2026

Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant

Jul 14, 2026

Closed $0.293 (+6.2%) on Jul 14, 2026

Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study

Jun 26, 2026

Closed $0.301 (+6.4%) on Jun 26, 2026

Ensysce Biosciences Reports First Quarter 2026 Financial Results

May 15, 2026

Closed $0.317 (+13.2%) on May 18, 2026

All Ensysce Biosciences, Inc. news

Financings

  • Private placement of series C non-voting convertible preferred stock

    Aug 13, 2026

    Tranche closed: US$21.5M raised · US$321.79 a share · Cantor +1

    Dealers: Cantor, UBS Investment Bank

    Buyers: Ally Bridge Group (led the private placement); Perceptive Advisors; Dellora Investments; Ikarian Capital; Adage Capital Partners, L.P.

    Use of proceeds: Advance CY200 through a randomized Phase 2 trial in CRPS Type 1 and prepare for registrational development

    Announced Aug 6, 2026 · Tranche closed Aug 13, 2026

Read by 6ix AI from the company's releases

Decks

Ensysce Biosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
27 in the last 12 months · 170 in all · newest Oct 21, 2026 · oldest 2021
Calls
7 calls with a replay · 7 with a transcript · latest Aug 18, 2026
Decks
8 decks · latest Aug 6, 2026

Where Ensysce Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ENSC · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ENSCBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Ensysce Biosciences, Inc.